ADAM33 Gene Polymorphisms are Associated with the Risk of Idiopathic Pulmonary Fibrosis

Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis

(2013) Hillary Loomis-King et al.   CURRENT OPINION IN PHARMACOLOGY

Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis

(2013) Anna L. Peljto et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Regulation ofA Disintegrin And Metalloprotease-33Expression by Transforming Growth Factor-β

(2012) Youwen Yang et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Angiogenesis in Pulmonary Fibrosis

(2012) Chandru Hanumegowda et al.   CHEST

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

(2011) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis

(2011) Thomas J. Richards et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Idiopathic pulmonary fibrosis

(2011) Talmadge E King et al.   LANCET

A CommonMUC5BPromoter Polymorphism and Pulmonary Fibrosis

(2011) Max A. Seibold et al.   NEW ENGLAND JOURNAL OF MEDICINE

The effects of Th2 cytokines on the expression of ADAM33 in allergen-induced chronic airway inflammation

(2009) Zhijun Jie et al.   RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY

PGA: power calculator for case-control genetic association analyses

(2008) Idan Menashe et al.   BMC GENETICS

Evaluation of coverage variation of SNP chips for genome-wide association studies

(2008) Mingyao Li et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis

(2008) Marco Checa et al.   HUMAN GENETICS